Case Report: The Different Fates of Three Aneurysms: Diagnosis and Treatment Strategies for Unruptured Intracranial Aneurysms With Other Intracranial Diseases

Abstract

Intracranial aneurysms are vascular diseases characterized by local aneurysms of intracranial arteries. Their etiology involves a variety of environmental and genetic factors. Unruptured intracranial aneurysms (UIAs) are more common in intracranial aneurysms, but once an aneurysm is ruptured, the fatality rate and disability rate are extremely high. Therefore, accurate assessment of each step in the detection of intracranial aneurysms, assessment of the risk of rupture, formulation of treatment strategies, and treatment benefits will help to better treat the disease. At present, the treatment of intracranial aneurysms is limited. Except for surgical intervention, there are no other effective methods. Therefore, when a patient has a UIA, the formulation of treatment and management strategies is a difficult issue facing neurosurgery. This article introduces the choice of different treatment strategies for 3 patients with intracranial aneurysms complicated with other diseases and reviews the literature.

Editorial: Update on Multidisciplinary Management of Surgical Neurovascular Pathologies

“…In their article “ Delayed Progressive Mass Effect After Secured Ruptured Middle Cerebral Artery Aneurysm: Risk Factors and Outcomes ” ( 4 ), Dr. Li and coworkers explored the risk and predictive factors of poor outcomes for those patients with a progressive mass effect after endovascular or surgical treatment of ruptured MCA aneurysms and underwent salvage surgery. In the article “ The different fates of three aneurysms: Diagnosis and treatment strategies for unruptured intracranial aneurysms with other intracranial diseases ” ( 5 ), Dr. Gaochao Guo and co-workers analyzed the possible treatment strategies for intracranial aneurysms complicated by other diseases in three different clinical scenarios. Lastly, in their interesting manuscript “ Monocyte count on admission is predictive of shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage ” ( 6 ), Dr. Cuoco and colleagues interestingly found that monocyte count ≥0.80 × 103/uL at admission predicts shunt-dependent hydrocephalus in patients with aneurysmal subarachnoid hemorrhage.…”